These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 11515383)

  • 21. Use of cholinesterase inhibitors for treatment of Alzheimer disease.
    Hake AM
    Cleve Clin J Med; 2001 Jul; 68(7):608-9, 613-4, 616. PubMed ID: 11453078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The new cholinesterase inhibitors for Alzheimer's disease, Part 1: their similarities are different.
    Stahl SM
    J Clin Psychiatry; 2000 Oct; 61(10):710-1. PubMed ID: 11078030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A case history illustrating how extended release cholinesterase inhibitors could improve management of Alzheimer's disease.
    Alisky JM
    J Alzheimers Dis; 2003 Dec; 5(6):477-8. PubMed ID: 14757938
    [No Abstract]   [Full Text] [Related]  

  • 24. Medical treatment of Alzheimer's disease: past, present, and future.
    Ott BR
    Med Health R I; 2002 Jul; 85(7):210-2. PubMed ID: 12182092
    [No Abstract]   [Full Text] [Related]  

  • 25. Cholinesterase inhibitors in Alzheimer's disease: donepezil or rivastigmine?
    Sharma JC
    Int J Clin Pract; 2002; 56(6):414-5. PubMed ID: 12166537
    [No Abstract]   [Full Text] [Related]  

  • 26. Guidelines for managing Alzheimer's disease: Part II. Treatment.
    Cummings JL; Frank JC; Cherry D; Kohatsu ND; Kemp B; Hewett L; Mittman B
    Am Fam Physician; 2002 Jun; 65(12):2525-34. PubMed ID: 12086242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Featured CME topic: dementia. Medication update.
    Slagle MA
    South Med J; 2001 Jul; 94(7):678-81. PubMed ID: 11531174
    [No Abstract]   [Full Text] [Related]  

  • 28. Third drug to treat Alzheimer's approved.
    Mayo Clin Health Lett; 2000 Aug; 18(8):4. PubMed ID: 10932951
    [No Abstract]   [Full Text] [Related]  

  • 29. Dementia.
    Warner J; Butler R; Prabhakaran P
    Clin Evid; 2003 Jun; (9):1010-33. PubMed ID: 12967405
    [No Abstract]   [Full Text] [Related]  

  • 30. The use, benefits, and costs of cholinesterase inhibitors for Alzheimer's dementia in long-term care: are the data relevant and available?
    Khang P; Weintraub N; Espinoza RT
    J Am Med Dir Assoc; 2004; 5(4):249-55. PubMed ID: 15228635
    [No Abstract]   [Full Text] [Related]  

  • 31. Cholinesterase inhibitor treatment and urinary incontinence in Alzheimer's disease.
    Starr JM
    J Am Geriatr Soc; 2007 May; 55(5):800-1. PubMed ID: 17493206
    [No Abstract]   [Full Text] [Related]  

  • 32. Alzheimer's disease: beware of interactions with cholinesterase inhibitors.
    Prescrire Int; 2006 Jun; 15(83):103-6. PubMed ID: 16764099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-Alzheimer drugs: life-threatening adverse effects.
    Prescrire Int; 2007 Feb; 16(87):16. PubMed ID: 17326275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholinesterase inhibitors: tremor and exacerbation of Parkinson's disease.
    Prescrire Int; 2007 Oct; 16(91):197-8. PubMed ID: 17926835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alzheimer's disease management.
    Cummings JL
    J Clin Psychiatry; 1998; 59 Suppl 13():4-5. PubMed ID: 9771824
    [No Abstract]   [Full Text] [Related]  

  • 36. [Anticholinesterase agents in Alzheimer's disease].
    Ventura M; Sternon J
    Rev Med Brux; 2001 Sep; 22(4):A387-93. PubMed ID: 11680206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of acetyl-L-carnitine in Alzheimer's disease patients unresponsive to acetylcholinesterase inhibitors.
    Bianchetti A; Rozzini R; Trabucchi M
    Curr Med Res Opin; 2003; 19(4):350-3. PubMed ID: 12841930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cholinesterase inhibitors for Alzheimer's disease.
    Grutzendler J; Morris JC
    Drugs; 2001; 61(1):41-52. PubMed ID: 11217870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Drug therapy strategies in Alzheimer's disease].
    Lacomblez L
    Rev Prat; 1998 Nov; 48(17):1913-7. PubMed ID: 9854394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Realistic expectations for treatment success in Alzheimer's disease.
    Geldmacher DS; Frolich L; Doody RS; Erkinjuntti T; Vellas B; Jones RW; Banerjee S; Lin P; Sano M
    J Nutr Health Aging; 2006; 10(5):417-29. PubMed ID: 17066215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.